Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Assembly Biosciences, Inc. (ASMB) had Free Cash Flow per Share of $-1.31 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$8.21M |
|
$-9.08M |
|
-- |
|
$8.21M |
|
$19.58M |
|
$-11.37M |
|
$2.29M |
|
$-9.08M |
|
$-9.08M |
|
$-9.08M |
|
$-9.08M |
|
$-9.08M |
|
$-9.08M |
|
$-11.37M |
|
$-12.13M |
|
16.90M |
|
16.90M |
|
$-0.54 |
|
$-0.54 |
|
| Balance Sheet Financials | |
$232.61M |
|
$0.21M |
|
$2.90M |
|
$235.51M |
|
$35.00M |
|
-- |
|
$1.90M |
|
$36.90M |
|
$198.61M |
|
$198.61M |
|
$198.61M |
|
15.89M |
|
| Cash Flow Statement Financials | |
$-22.10M |
|
$-5.38M |
|
$0.15M |
|
$58.45M |
|
$31.12M |
|
$-27.33M |
|
$1.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.65 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-138.44% |
|
-138.44% |
|
-- |
|
-110.54% |
|
-110.54% |
|
$-22.12M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
18.21 |
|
4.94 |
|
-4.57% |
|
-4.57% |
|
-3.86% |
|
-4.57% |
|
$12.50 |
|
|
Free Cash Flow per Share |
$-1.31 |
$-1.31 |
|